Georgia's Online Cancer Information Center

Neurologocal Tumor Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Neurologocal Tumor
Cancer Type = Neurologocal Tumor
There are currently 5 active Neurologocal Tumor clinical trials in Georgia.
1.
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Cancer Type
Bone Tumor, Neuroblastoma, Neurologocal Tumor
NCT ID
NCT02573896
Protocol IDs
NANT 2013-01
NCI-2019-00106
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
Howard M. Katzenstein, MD
404-785-0853
2.
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients with Non-high Risk Neuroblastoma
Cancer Type
Neuroblastoma, Neurologocal Tumor
NCT ID
NCT02176967
Protocol IDs
ANBL1232
NCI-2014-00677
U10CA098543
U10CA180886
Treatment Sites (1)
3.
Standard Chemotherapy in Treating Young Patients with Medulloblastoma or Other Central Nervous System Embryonal Tumors
Cancer Type
Brain & Spinal Cord Tumor, Brain Tumor, Neuroblastoma, Neurologocal Tumor
NCT ID
NCT02875314
Protocol IDs
NCH-15004
NCI-2016-01993
IRB15-00399
Treatment Sites (1)
Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
Howard M. Katzenstein, MD
404-785-0853
4.
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People with High-Risk Neuroblastoma (NBL)
Cancer Type
Neuroblastoma, Neurologocal Tumor
NCT ID
NCT03126916
Protocol IDs
ANBL1531
ANBL1531
NCI-2016-01734
Treatment Sites (1)
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.